Clearside Biomedical, Inc. (CLSDQ) vs Windtree Therapeutics, Inc. (WINT)

Clearside Biomedical, Inc. and Windtree Therapeutics, Inc. are both Biotechnology companies. Clearside Biomedical, Inc. and Windtree Therapeutics, Inc. are of similar size ($2.4M and $2.2M). Clearside Biomedical, Inc. grew revenue faster over the last twelve months: −56.8% against −68.4%. Windtree Therapeutics, Inc. has the higher net margin (0.00% vs −780.9%) and the lower return on invested capital (−386.3% vs 0.00%). Across the 16 metrics below, Windtree Therapeutics, Inc. leads on 9 and Clearside Biomedical, Inc. on 7.

Valuation

Metric CLSDQ WINT Biotechnology median
P/E n/m n/m 7.88
P/S 0.39 n/m 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 10.91 63.80 10.73
Earnings yield (2,075.24%) 0.00% (28.84%)
Free cash flow yield (1,661.90%) 0.00% (23.03%)

Profitability

Metric CLSDQ WINT Biotechnology median
Gross margin 92.55% 0.00% 65.16%
Operating margin (689.76%) 0.00% 0.00%
Net margin (780.93%) 0.00% 0.00%
Free cash flow margin (653.23%) 0.00% 0.00%
Return on equity 58.59% 1,356.23% (57.72%)
Return on assets (127.43%) (210.34%) (49.22%)
Return on invested capital 0.00% (386.34%) 0.00%

Growth

Metric CLSDQ WINT Biotechnology median
Revenue growth (TTM) (56.78%) (68.35%) 5.64%
EPS growth (last fiscal year) 11.32% 97.79% —
Revenue growth, 5-year CAGR (5.20%) (41.28%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLSDQ WINT Biotechnology median
Debt to equity 0.00 (1.48) 0.00
Current ratio 2.98 0.33 4.73
Net debt to EBITDA 0.69 0.03 0.96

Dividend

Metric CLSDQ WINT Biotechnology median
Dividend yield — 4.38% 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CLSDQ WINT Biotechnology median
Market cap 2.15m 2.35m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack